A. S. Krapivina

A. S. Krapivina

Auto-generated profile, based on publicly available information

A. S. Krapivina

Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia (Cardiology Research Institute, Tomsk NRMC)

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2023 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
OKOlga Koshelskaya
Olga Koshelskaya
Natalia NaryzhnayaNatalia Naryzhnaya
Natalia Naryzhnaya
IKIrina Kologrivova
Irina Kologrivova
TSTatiana E. Suslova
Tatiana E. Suslova
EKElena Kravchenko
Elena Kravchenko
AKA. S. Krapivina
A. S. Krapivina
The changes of epicardial adipose tissue’s (EAT) morphofunctional characteristics represent an important factor of cardiometabolic impairments development. However, factor data determining the severity of EAT adipocytes’ hypertrophy in patients with coronary atherosclerosis are absent in literature.Aim: To compare the size of the EAT adipocyte and the percentage of hypertrophied adipocytes with the parameters of glucose/insulin metabolism, blood lipid transport function, adipokines’ profile and serum levels of high sensitive C-reactive protein (hsCRP) in patients with chronic coronary artery disease (CAD) undergoing coronary artery bypass grafting (CABG); to establish statistically significant determinants of a pronou ced degree of EAT adipocytes’ hypertrophy.Material and Methods. The study included 42 patients (m/f 28/14) aged 53–72 y.o. with CAD, who underwent CABG. The material for the study was EAT adipocytes obtained by the enzymatic method from intraoperative explants. The basal blood levels of glycemia, insulinemia, C-peptide, blood lipid transport function, adipokines and hsCRP were determined. The median indicators of the size of EAT adipocytes and the proportion of EAT adipocytes over 100 μm were 87.32 μm and 14.64%, respectively. The total sample of patients was divided into two groups: gr. 1 with an average size of EAT adipocytes less than or equal to 87.32 μm and gr. 2 with an average size of EAT adipocytes more than 87.32 μm. Gr. 2 had higher body mass index, waist and hip circumferences, triglycerides, hsCRP, and lower adiponectin levels, while the median proportion of hypertrophied adipocytes was three times higher than in group 1. A model of multiple logistic regression was constructed, according to which statistically significant determinants of the pronounced EAT adipocytes’ hypertrophy are represented by the decreased level of adiponectin, and increased concentrations of hsCRP and C-peptide, which reflects the biosynthesis and secretion of insulin. The predictive accuracy of the model was 82%, sensitivity 85%, specificity 79%, AUC = 0.89.Conclusion. Our results indicate a close correlation between the development of EAT adipocytes hypertrophy, impaired production of adiponectin, insulin, and inflammation processes. Concentrations of adiponectin, hsCRP, and basal C-peptide in the blood are biomarkers that accurately determine the presence of EAT adipocyte hypertrophy.

30 September 2024 in Kardiologiia
Verified
Journal Article
Open access
PDF file
OKOlga Koshelskaya
Olga Koshelskaya
EKElena Kravchenko
Elena Kravchenko
Natalia NaryzhnayaNatalia Naryzhnaya
Natalia Naryzhnaya
IKIrina Kologrivova
Irina Kologrivova
AKA. S. Krapivina
A. S. Krapivina
TSTatiana E. Suslova
Tatiana E. Suslova
Aim. To assess the potential relationship between morphometric characteristics of adipocytes in epicardial and subcutaneous adipose tissue (EAT, SAT) and the lipid transport function of the blood, glucose e metabolism, and inflammatory biomarkers in patients with ischemic heart disease (IHD) after coronary artery bypass grafting. Material and methods. The study included 47 patients (33 men and 14 women) aged 53-72 years with chronic IHD. The study material was EAT and SAT adipocytes obtained from intraoperative explants. The size of EAT and SAT adipocytes and the proportion of EAT and SAT adipocytes with ≥100 μm and ≤50 μm sizes were determined. Carbohydrate metabolism parameters, blood lipid transport function, and inflammatory biomarkers were assessed. Surrogate indices of insulin resistance (IR) were calculated. Results . The mean size of EAT adipocytes, in contrast to SAT adipocytes, correlated (p<0.05) with serum concentrations of tumor necrosis factor alpha (TNF-α) (rs=0.43), triglycerides (TG) (rs=0.36), interleukin (IL)-1β (rs=0.29), basal C-peptide (rs=0.40) and TyG index (rs=0.32). Male gender and blood concentrations of basal C-peptide and TG in combination were identified as statistically significant determinants of an increase in the mean size of EAT adipocytes. The threshold values of TG and non-high-density lipoprotein cholesterol (nHDL-C) associated with an increase in the mean size of EAT adipocytes ≥87.61 μm were 1.4 and 2.63 mM, respectively. Patients with TG concentrations ≥1.4 mM had a greater size and proportion of hypertrophied EAT adipocytes, IR indices, and higher blood concentrations of basal glucose, high-sensitivity C-reactive protein, TNF-α, and IL-1β. TG concentrations of 1.2-1.4 mM, compared with concentrations <1.2 mM, were associated with a greater mean size of EAT adipocytes and higher serum IL-10 concentrations. Patients with non-HDL-C ≥2.63 mM, compared with its lower concentrations, had more pronounced hypertrophy of EAT adipocytes. Conclusion . Disorders in the morphometric characteristics of EAT adipocytes, in contrast to SAT adipocytes, are associated with increased blood concentrations of TG, non-HDL-C, inflammatory markers, and increased IR indices. It was shown for the first time that a combination of three factors, male gender, blood concentrations of basal C-peptide, and TG, independently of other indicators describe the variability of the mean size of EAT adipocytes. Increases in TG from 1.2 to 1.4 mM are associated with a larger size of EAT adipocytes and cytokine imbalance. Our data confirm the validity of identifying optimal blood concentrations of TG and non-HDL-C in patients with IHD and coronary atherosclerosis.

13 April 2025 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
NRN. V. Rebrova
N. V. Rebrova
AKA. S. Krapivina
A. S. Krapivina
NSN. N. Sviazova
N. N. Sviazova
NSN. V. Shcherban
N. V. Shcherban
Ivan V. StepanovIvan V. Stepanov
Ivan V. Stepanov
KLK. S. Likhomanov
K. S. Likhomanov
Aortitis and aortic valve insufficiency are referred to as extraskeletal manifestations of ankylosing spondylitis (AS). Torpid course of diseases is the reason for late seeking medical care at the stage of irreversible changes and severe dysfunction of the cardiovascular and musculoskeletal systems. The article presents a clinical case of successful surgical treatment of severe aortic valve insufficiency in a patient with late diagnosed AS. The problems of cardiovascular pathology in AS, interdisciplinary interaction of doctors, choice of antirheumatic therapy and perioperative management of a very high cardiovascular risk patient with AS are discussed.